FountainBlue's Life Science Entrepreneurs' Forum November 16, 2009

Personalized Medicine, Biomarkers, Invitro Diagnostics: The Science Advances, The Business Opportunities, The Cultural Dilemmas

The accelerated pace of technology advancements is opening up new offerings in personalized medicine, in biomarker training, in Invitro diagnostics. This month we feature groundbreaking leaders to showcase advances and opportunities in this market and touch upon cultural and moral dilemmas which arise as these offerings gain traction.
• Facilitator Linda K. Molnar, LKM Strategic Consulting
• Panelist Kim Caple, Senior Director and General Manager of the Applied Biosystems Genetic Analysis Business, Applied Biosystems, a Life Technologies Company
• Panelist Doug Dolginow, PhD, BOD, Advisor, Founder CSO/CMO, Veracyte, Inc, and CEO and BOD, NanoValent
• Panelist Ted Driscoll, Venture Partner, Claremont Ventures; Active Member, Life Science Angels; Founding Director, Sand Hill Angels
• Presenting Entrepreneur Richard A. Goozh, Sr. VP, Strategy & Finance, Wave 80 Biosciences; Managing Director, Cambrian Partners
• Presenting Entrepreneur Dick Haiduck, Partner to the CEO, Implicit Bioscience and Cytopia
• Another Presenting Entrepreneur to be confirmed, your recommendations and nominations for early-stage, funding-bound entrepreneurs are welcome

Information and Registration: NO SERVICE PROVIDERS PLEASE.
• Additional information about our life science entrepreneurs' forum and notes from our previous meetings are available at http://www.SVLifeScience.com.

Official Website: http://www.svlifescience.com